Concepedia

Cyrille S. Kounde

CS

Statistics

Publications

8

Citations

692

H-Index

8

Active since

2009

Affiliations

Imperial College London(Current)

Novartis (Switzerland)

Novartis (Singapore)

GlaxoSmithKline (United Kingdom)

Novartis Institutes for BioMedical Research

Cyrille S. Kounde is an author at Imperial College London specializing in medicinal chemistry, pharmacology, and protein degradation.

ORCID

Publications per year

2009–2022

8

Publications

8

Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4

Marı́a Maneiro, Nafsika Forte, Maria M. Shchepinova et al. · ACS Chemical Biology · 2020 · 324 citations · Full text

, , +17

A caged E3 ligase ligand for PROTAC-mediated protein degradation with light

Cyrille S. Kounde, Maria M. Shchepinova, Charlie N. Saunders et al. · Chemical Communications · 2020 · 127 citations · Full text

, , +12

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

Stephanie Moquin, Oliver Simon, Ratna Karuna et al. · Science Translational Medicine · 2021 · 93 citations

, , +17

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)

Qisi Zhang, Cyrille S. Kounde, Milon Mondal et al. · Chemical Communications · 2022 · 52 citations · Full text

, , +11

Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Antitubercular Agents

Fumiaki Yokokawa, Gang Wang, Wai Ling Chan et al. · ACS Medicinal Chemistry Letters · 2013 · 48 citations

, , +17

1–5 of 8